You are here:
Home / Archives for alliances
Vincent G. Brichard, Senior Vice President and Head of the Immunotherapeutics Business Unit at GlaxoSmithKline Biologicals will give a keynote presentation on the “Development of Active Immunization against Cancer: The Example of MAGE-A3” at the Immunotherapeutics Partnering and Deal-making Conference to be held in San Diego, CA on January 30-31, 2012 by GTC. Dr. Brichard [...]
Posted by GTCbio on Thursday, December 29, 2011 at 11:09 pm
Filed under Technology · Tagged Allergy, alliances, Antibodies, Antibody, antigen, Auto-immune Disease, autoimmune, autoimmunity, bi-specific, Cancer, deals, GSK cancer immunotherapeutic, GSK Deals, GSK Partnering, Immune, immunology, Immunotherapeutics, Immunotherapy, investments, licensing, mergers, merges, neuroscience, partnerships, Peptide, specific, T Cell, trends, vaccine, vaccines
Leslie J. Williams, President and CEO at ImmusanT will give a presentation on “ImmusanT’s Development of an Immunotherapeutic Vaccine for Celiac Disease” at the Immunotherapeutics Partnering and Deal-making Conference to be held in San Diego, CA on January 30-31, 2012 by GTC. Celiac Disease is an inherited autoimmune disease triggered by the consumption of foods [...]
Posted by GTCbio on Thursday, December 29, 2011 at 11:08 pm
Filed under Technology · Tagged ADC, Allergy, alliances, Antibodies, Antibody, Antibody Drug Conjugate, antigen, antigen specific, ATP, Auto-immune Disease, autoimmune, autoimmunity, bi-specific, Biomarker discovery, Biomarker validation, biomarkers, BiTE Antibodie, Cancer, cancer drug, Cancer Target, Cancer Therapeutic, cancer vaccine, celiac disease, Clinical trials Pharmaceutical, Combinational Therapy, companion diagnostics, Companion tests, deals, Diagnostics reimbursements, Discovery and validation, drug development, Epigenetic, genomics, Hedgehog, HER-2, Immune, immunology, Immunotherapeutics, Immunotherapy, in vitro, In vivo, inhibitor, investments, licensing, mergers, merges Vaccine, neuroscience, Next generation sequencing, Novel approaches, Novel technologies, ocular allergy, oncology, partnering, partnerships, Peptide, personalized medicine, PI3K, Protein Kinase Drug discovery, Proteomics Clinical translation, RNAi based therapy, Sequencing Targeted oncology, T Cell, Therapeutic Vaccine, trends, vaccines
Bilingual Experts, a Canadian recruiting company serving clients since 1974 – entered unique strategic alliances with leading Russian staffing firms. Toronto, ON, November 04, 2009 — In today’s global economy, having top-notch professionals on board means the difference between failure and success. However, more often than not North American companies – true leaders in such [...]